Doxorubicin Treatment Activates a Z-VAD-Sensitive Caspase, Which Causes ΔΨm Loss, Caspase-9 Activity, and Apoptosis in Jurkat Cells
- 10 July 2000
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 258 (1), 223-235
- https://doi.org/10.1006/excr.2000.4924
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Ceramide in apoptosis—does it really matter?Trends in Biochemical Sciences, 1998
- Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide signalling pathwayCell Death & Differentiation, 1998
- Doxorubicin‐induced apoptosis in human T‐cell leukemia is mediated by caspase‐3 activation in a Fas‐independent wayFEBS Letters, 1997
- Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells: Chemotherapy-Induced Apoptosis Is Not Dependent on Fas/Fas Ligand InteractionsBlood, 1997
- Cytokine Response Modifier A (CrmA) Inhibits Ceramide Formation in Response to Tumor Necrosis Factor (TNF)-α: CrmA and Bcl-2 Target Distinct Components in the Apoptotic PathwayThe Journal of Experimental Medicine, 1997
- Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cellsNature Medicine, 1996
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cellsBiochemical Pharmacology, 1993
- Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermiaBiochemical Pharmacology, 1990